Troy Cox joined Foundation Medicine in 2017 as its Chief Executive Officer. He’s driven by improving the lives of patients. Prior to joining Foundation Medicine, Troy served as Senior Vice President and Officer at Genentech, where he led US BioOncology, the #1 Oncology Company fueled by over 1,500 people passionately delivering for patients. He serves on the boards of Dream Foundation and the Healthcare Businesswomen’s Association (H.B.A) San Francisco Chapter.
Troy joined Genentech in February 2010. Prior to taking BioOncology leadership in 2013, he led diverse in-market specialty and primary care franchises as well as US market preparation for 6 new medicines. Further, he was selected to lead the worldwide launch readiness for two high priority launches. Troy has over 25 years of extensive and diverse BioPharma experience and has contributed to over 20 product launches. Before coming to Genentech, Troy had global P&L responsibility for Specialty Commercial Operations including Sales, Marketing, and Medical Affairs at UCB BioPharma. Prior to UCB, Troy led a large US Primary Care Business Unit for Sanofi-Aventis. He also led Global Marketing and Medical for Anti-Infectives at Aventis. Troy’s diverse experience includes senior roles in European Country General Management, US Managed Care Sales Leadership, and US Claritin Marketing with Schering-Plough. His pharmaceutical career began as a Sales Representative after earning his MBA at the University of Missouri. He also received a BBA in Finance from the University of Kentucky.